BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
+19.43%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$4B
AUM Growth
+$4B
Cap. Flow
-$156M
Cap. Flow %
-3.89%
Top 10 Hldgs %
61.89%
Holding
76
New
7
Increased
10
Reduced
7
Closed
6

Top Buys

1
RVMD icon
Revolution Medicines
RVMD
$57.4M
2
SNDX icon
Syndax Pharmaceuticals
SNDX
$40.5M
3
ACIU icon
AC Immune
ACIU
$35.7M
4
ANNX icon
Annexon
ANNX
$31.8M
5
ETNB icon
89bio
ETNB
$24.6M

Top Sells

1
IDYA icon
IDEAYA Biosciences
IDYA
$126M
2
IONS icon
Ionis Pharmaceuticals
IONS
$79.7M
3
PNT
POINT Biopharma Global Inc. Common Stock
PNT
$70.5M
4
ACRS icon
Aclaris Therapeutics
ACRS
$48.4M
5
XENE icon
Xenon Pharmaceuticals
XENE
$43.2M

Sector Composition

1 Healthcare 99.98%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SNDX icon
26
Syndax Pharmaceuticals
SNDX
$1.38B
$40.5M 1.01%
+1,875,000
New +$40.5M
TYRA icon
27
Tyra Biosciences
TYRA
$659M
$37.9M 0.95%
2,739,595
– –
LXRX icon
28
Lexicon Pharmaceuticals
LXRX
$396M
$37.4M 0.94%
24,435,632
+4,440,300
+22% +$6.79M
GPCR icon
29
Structure Therapeutics
GPCR
$1.14B
$33.1M 0.83%
812,988
-937,012
-54% -$38.2M
CGEM icon
30
Cullinan Oncology
CGEM
$453M
$32.6M 0.82%
3,196,701
– –
ANTX icon
31
AN2 Therapeutics
ANTX
$33.6M
$32M 0.8%
1,563,963
– –
ANNX icon
32
Annexon
ANNX
$229M
$31.8M 0.8%
+7,000,000
New +$31.8M
ROIV icon
33
Roivant Sciences
ROIV
$8.54B
$30.8M 0.77%
2,742,409
– –
SLN
34
Silence Therapeutics
SLN
$235M
$26.2M 0.66%
1,508,416
– –
ALLK
35
DELISTED
Allakos
ALLK
$23.3M 0.58%
8,552,417
– –
CBIO
36
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
$22.5M 0.56%
9,544,262
– –
OVID icon
37
Ovid Therapeutics
OVID
$91.7M
$22.1M 0.55%
6,851,051
– –
ENGN icon
38
enGene Holdings
ENGN
$243M
$20.8M 0.52%
+2,251,037
New +$20.8M
CALT
39
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
$19.3M 0.48%
750,000
– –
TCRX icon
40
TScan Therapeutics
TCRX
$103M
$17.4M 0.44%
2,989,474
– –
NAMS icon
41
NewAmsterdam Pharma
NAMS
$2.83B
$17M 0.43%
1,521,948
– –
SYRE icon
42
Spyre Therapeutics
SYRE
$1.01B
$14.8M 0.37%
+687,080
New +$14.8M
STRO icon
43
Sutro Biopharma
STRO
$83.1M
$14.4M 0.36%
3,347,946
– –
ITOS
44
DELISTED
iTeos Therapeutics
ITOS
$13.8M 0.35%
1,259,476
– –
VSTM icon
45
Verastem
VSTM
$567M
$13.7M 0.34%
1,685,219
– –
IMVT icon
46
Immunovant
IMVT
$2.85B
$12.6M 0.32%
300,000
– –
VTGN icon
47
VistaGen Therapeutics
VTGN
$110M
$10.3M 0.26%
+2,000,000
New +$10.3M
CTMX icon
48
CytomX Therapeutics
CTMX
$343M
$10.2M 0.26%
6,595,801
– –
IMA
49
ImageneBio, Inc. Common Stock
IMA
$154M
$9.4M 0.24%
4,769,164
+1,600,000
+50% +$3.15M
VERV
50
DELISTED
Verve Therapeutics
VERV
$9.06M 0.23%
650,000
– –
1
2
3 4